Sagimet Biosciences (SGMT) Earnings Date, Estimates & Call Transcripts $3.71 -0.05 (-1.33%) Closing price 04:00 PM EasternExtended Trading$3.71 0.00 (0.00%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Sagimet Biosciences Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 21EstimatedActual EPS (Mar. 12) -$0.50 Beat By $0.15 Consensus EPS (Mar. 12) -$0.65 Sagimet Biosciences posted Q4 2024 earnings on March 12, 2025, reporting an EPS of -$0.50, which topped analysts' consensus estimates of -$0.65 by $0.15. With a trailing EPS of -$1.43, Sagimet Biosciences' earnings are expected to decrease next year, from ($1.60) to ($4.03) per share. SGMT Upcoming EarningsSagimet Biosciences' next earnings date is estimated for Wednesday, May 21, 2025, based off prior year's reporting schedules. Get Sagimet Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sagimet Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSGMT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SGMT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Sagimet Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$1.00-$1.00-$1.00Q2 20251-$1.22-$1.22-$1.22Q3 20251-$1.31-$1.31-$1.31Q4 20251-$1.34-$1.34-$1.34FY 20254($4.87)($4.87)($4.87) Remove Ads Sagimet Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/21/2025(Estimated)-------3/12/2025Q4 2024-$0.65-$0.50+$0.15-$0.50--8/14/2024--$0.34-$0.25+$0.09-$0.25--5/15/2024Q1 2024-$0.41-$0.23+$0.18-$0.23--11/13/2023Q3 2023-$1.02-$0.35+$0.67-$0.35-$2.00M8/21/2023Q2 2023-$0.50-$35.80 -$35.30-$35.80-- Sagimet Biosciences Earnings - Frequently Asked Questions When is Sagimet Biosciences's earnings date? Sagimet Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 21st, 2025 based off last year's report dates. Learn more on SGMT's earnings history. Did Sagimet Biosciences beat their earnings estimates last quarter? In the previous quarter, Sagimet Biosciences (NASDAQ:SGMT) reported ($0.50) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.65) by $0.15. Learn more on analysts' earnings estimate vs. SGMT's actual earnings. How much revenue does Sagimet Biosciences generate each year? Sagimet Biosciences (NASDAQ:SGMT) has a recorded annual revenue of $2 million. How much profit does Sagimet Biosciences generate each year? Sagimet Biosciences (NASDAQ:SGMT) has a recorded net income of -$27.88 million. SGMT has generated -$1.43 earnings per share over the last four quarters. What is Sagimet Biosciences's EPS forecast for next year? Sagimet Biosciences's earnings are expected to decrease from ($1.60) per share to ($4.03) per share in the next year. More Earnings Resources from MarketBeat Related Companies Sage Therapeutics Earnings Results Cullinan Therapeutics Earnings Results Trevi Therapeutics Earnings Results Akebia Therapeutics Earnings Results Altimmune Earnings Results Keros Therapeutics Earnings Results Oruka Therapeutics Earnings Results Phathom Pharmaceuticals Earnings Results Autolus Therapeutics Earnings Results Tourmaline Bio Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Intuitive Machines Gains After Earnings Beat, NASA Missions AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss Remove Ads This page (NASDAQ:SGMT) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredRevealed: The Chip Stock Redefining AI as We Know ItIn this urgent presentation, Wall Street's so-called "AI Oracle" unveils the name of a small American tech fir...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sagimet Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sagimet Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SGMT Stock Free SGMT Stock Alerts